VEGFA and osteonecrosis: Moreover, several genetic polymorphisms of VEGF are associated with susceptibility to nontraumatic osteonecrosis [49,50,51], while a reduction in circulating VEGF-C is associated with the development of osteonecrosis of the jaw in patients receiving bisphosphonate [52].